A highly selective open channel blocker that targets If carried by HCN channels; suppresses channel activity at HCN1, HCN2, and HCN4, all with the same EC50 value of 4 µM; selectively targets cardiac signaling, resulting in resting heart rate reducing (bradycardic) effects.